Andere talen Concord Drugs Limited

Aandelen

CONCORD6

INE858L01010

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:58 10-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
41,12 ^INR	-5,06%		+11,05%	-31,15%

30/05	Concord Drugs Limited rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 maart 2024	CI
19/03	Concord Drugs Limited kondigt benoeming aan van Namratha Nagla als bedrijfssecretaris/compliance officer	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Concord Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05
Concord Drugs Limited Announces Appointment of Namratha Nagla as Company Secretary/Compliance Officer	19/03
Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02
Concord Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14-08-23
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14-08-23
Concord Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30-05-23
Concord Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30-05-23
Concord Drugs Eyes INR 207 Million Rights Issue	14-04-23
Concord Drugs Limited Announces Resignation of AnkurBisht, Company Secretary and Compliance Officer	08-04-23
Concord Drugs Limited acquired 100% stake in Proton Remedies Private Limited for INR 14.2 million.	23-03-23
Concord Drugs Limited Appoints Mr. Ankur Bisht as Company Secretary and Compliance Officer, Effective on February 16, 2023	14-02-23
Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14-02-23
Concord Drugs Limited Announces Resignation of Rakshit Sethiya as Company Secretary and Compliance Officer	11-11-22
Concord Drugs Limited announced that it has received INR 10.364063 million in funding	07-11-22
Concord Drugs Limited Appoints RakshitSethiya as Company Secretary and Compliance Officer	04-11-22
Concord Drugs Limited announced that it expects to receive INR 10.364063 million in funding	07-09-22
Concord Drugs Limited agreed to acquire 100% stake in Proton Remedies Private Limited.	07-09-22
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13-08-22
Concord Drugs Limited Announces Director Changes	02-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Concord Drugs Limited

Aandelen

CONCORD6

INE858L01010

Andere talen

Filters